Government, industry deadlocked in negotiations over generic drug prices
Negotiations between government and industry on access to generic pharmaceuticals have reached an impasse over whether drug prices should go lower despite rising production costs. The pan-Canadian Pharmaceutical Alliance (pCPA) – which represents major government buyers such as provincial health…#canadiangenericpharmaceuticalassociat #michelrobidoux #sandozcanada #pharmascienceinc #ford #atenolol #canadians #pharmasciencecanada #subaru #chevrolet (Source: Reuters: Health)
Source: Reuters: Health - December 11, 2022 Category: Consumer Health News Source Type: news
Clopidogrel Recall; COAPT Score; Pediatric Cardiologist's Child Porn
(MedPage Today) -- FDA advised that generic lots of atenolol and clopidogrel (Plavix) are under recall due to a label mix-up by manufacturer Golden State Medical Supply.
LivaNova's LifeSPARC advanced circulatory support system has its controller... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 4, 2022 Category: Cardiology Source Type: news
Golden State Medical Supply, Inc. Issues a Voluntary Nationwide Recall of Atenolol 25 mg Tablets and Clopidogrel 75 mg Tablets Due to a Label Mix-up
Golden State Medical Supply, Incorporated (GSMS, Inc.) - Camarillo, CA has initiated a voluntary recall of the products listed in the table below because a report was received that a bottle containing Clopidogrel 75mg Tablets produced with lot# GS046745 was mislabeled as Atenolol 25mg Tablets. This (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - September 30, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news
atenolol
Title: atenololCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 2/2/2022 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - February 2, 2022 Category: Cardiology Source Type: news
Neuromics-3D Human Blood Brain Barrier!
Compound Penetration Study Classification: Low permeability: Pe< 1.00 nm/s Moderate permeability: 1.00< Pe< 10.0 nm/s High permeability: Pe> 10.0 nm/s * The signal responses of Atenolol , Sulpiride, and Cimetidine in receiver samples were undetectable.For the convenience of calculation, 1/300 of the measured peak area ratio (PAR) of the relevant AD (A>B Donor) samples were used as the PAR values of Atenolol , Sulpiride, and Cimetidine in receiver samples.Check out the study-https://www.neuromics.com/ittrium/reference/D8xf65cx8x1/BBB%20Penetration%20Data.pdf ...
Source: Neuromics - October 6, 2021 Category: Neuroscience Source Type: news
ASCOT: Amlodipine Cuts Stroke, Not Dementia Over Decades ASCOT: Amlodipine Cuts Stroke, Not Dementia Over Decades
Long-term follow up of the ASCOT trial comparing amlodipine- vs atenolol-based antihypertensive regimens shows reductions in stroke, but not dementia, with amlodipine over time.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - June 17, 2020 Category: Cardiology Tags: Neurology & Neurosurgery News Source Type: news
AstraZeneca completes divestment agreement with Atnahs Pharma for established hypertension medicines
AstraZeneca today announced that it has completed the previously communicated agreement with Atnahs Pharma (Atnahs) to divest its global commercial rights to Inderal (propranolol), Tenormin (atenolol), Tenoretic (atenolol, chlorthalidone fixed-dose combination), Zestril (lisinopril) and Zestoretic (lisinopril, hydrochlorothiazide fixed-dose combination). (Source: World Pharma News)
Source: World Pharma News - March 2, 2020 Category: Pharmaceuticals Tags: Featured AstraZeneca Business and Industry Source Type: news
AstraZeneca divests rights to established hypertension medicines
AstraZeneca has agreed to sell the global commercial rights to Inderal (propranolol), Tenormin (atenolol), Tenoretic (atenolol, chlorthalidone fixed-dose combination), Zestril (lisinopril) and Zestoretic (lisinopril, hydrochlorothiazide fixed-dose combination) to Atnahs Pharma (Atnahs). (Source: World Pharma News)
Source: World Pharma News - January 27, 2020 Category: Pharmaceuticals Tags: Featured AstraZeneca Business and Industry Source Type: news
atenolol, Tenormin
Title: atenolol, TenorminCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 6/26/2019 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - June 26, 2019 Category: Cardiology Source Type: news
Metoprolol vs. atenolol
Title: Metoprolol vs. atenololCategory: MedicationsCreated: 5/8/2019 12:00:00 AMLast Editorial Review: 5/8/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - May 8, 2019 Category: Drugs & Pharmacology Source Type: news
AUA: Atenolol Linked to Drop in Low - , Intermediate - Risk Prostate Cancer
After adjustment for confounders, atenolol displayed significant protective effect on prostate cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 4, 2019 Category: Cancer & Oncology Tags: Oncology, Pharmacy, Urology, Conference News, Source Type: news
Could Common Heart Meds Lower Prostate Cancer Risk?
The effect was found only with atenolol (Tenormin). Two other beta blockers -- metoprolol (Lopressor/Toprol XL) and carvedilol (Coreg) -- did not appear to provide any protection against prostate cancer. (Source: WebMD Health)
Source: WebMD Health - May 3, 2019 Category: Consumer Health News Source Type: news
AUA: Atenolol Linked to Drop in Low-, Intermediate-Risk Prostate Cancer
FRIDAY, May 3, 2019 -- Atenolol is associated with a reduction in incident intermediate- and low-risk prostate cancer (PCa), according to a study presented at the annual meeting of the American Urological Association, held from May 3 to 6 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 3, 2019 Category: Pharmaceuticals Source Type: news
Could Common Heart Meds Lower Prostate Cancer Risk?
FRIDAY, May 3, 2019 -- Good news for men: That blood pressure medication you ' re taking might be doing double duty, helping reduce your risk of developing prostate cancer, a new study shows.
Researchers found that a beta blocker called atenolol cut... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 3, 2019 Category: General Medicine Source Type: news
Beta blockers: Do they cause weight gain?
Yes. Weight gain can occur as a side effect of some beta blockers, especially the older ones, such as atenolol (Tenormin) and metoprolol (Lopressor, Toprol-XL). The average weight gain is about 2.6 pounds (about 1.2 kilograms). Newer beta blockers, such as carvedilol (Coreg), don't usually cause weight gain as a side effect. Weight may rise [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - February 19, 2019 Category: Databases & Libraries Source Type: news
